Department of Cellular Biology and Anatomy,Medical College of Georgia and Charlie Norwood VA Medical Center, 1459 Laney Walker Blvd., Augusta, GA 30912, USA.
Mol Med. 2010 Sep-Oct;16(9-10):409-16. doi: 10.2119/molmed.2010.00002. Epub 2010 Apr 9.
MicroRNAs are small noncoding RNAs that are produced endogenously and have emerged as important regulators in pathophysiological conditions such as development and tumorigenesis. Very little is known about the regulation of microRNAs in renal diseases, including acute kidney injury (AKI). In this study, we examined the regulation of microRNA-34a (miR-34a) in experimental models of cisplatin-induced AKI and nephrotoxicity. By Northern blot and real-time polymerase chain reaction analyses, we detected an induction of miR-34a in vitro during cisplatin treatment of mouse proximal tubular cells and also in vivo during cisplatin nephrotoxicity in C57BL/6 mice. In cultured cells, miR-34a was induced within a few hours. In mice, miR-34a induction was detectable in renal tissues after 1 d of cisplatin treatment and increased to approximately four-fold of control at d 3. During cisplatin treatment, p53 was activated. Inhibition of p53 with pifithrin-α abrogated the induction of miR-34a during cisplatin treatment of proximal tubular cells. In vivo, miR-34a induction by cisplatin was abrogated in p53-deficient mice, a result that further confirms a role for p53 in miR-34a induction during cisplatin nephrotoxicity. Functionally, antagonism of miR-34a with specific antisense oligonucleotides increased cell death during cisplatin treatment. Collectively, the results suggest that miR-34a is induced via p53 during cisplatin nephrotoxicity and may play a cytoprotective role for cell survival.
微小 RNA 是内源性产生的小非编码 RNA,已成为发育和肿瘤发生等病理生理条件下的重要调节剂。关于肾脏疾病(包括急性肾损伤 (AKI))中微小 RNA 的调节知之甚少。在这项研究中,我们研究了顺铂诱导的 AKI 和肾毒性的实验模型中微小 RNA-34a (miR-34a) 的调节。通过 Northern blot 和实时聚合酶链反应分析,我们在体外顺铂处理小鼠近端肾小管细胞过程中和体内 C57BL/6 小鼠顺铂肾毒性过程中检测到 miR-34a 的诱导。在培养的细胞中,miR-34a 在数小时内被诱导。在小鼠中,在顺铂处理 1 天后可以在肾脏组织中检测到 miR-34a 的诱导,并且在第 3 天增加到对照的约四倍。在顺铂处理过程中,p53 被激活。用 pifithrin-α 抑制 p53 可消除顺铂处理近端肾小管细胞时 miR-34a 的诱导。在体内,p53 缺陷型小鼠中顺铂诱导的 miR-34a 被消除,这进一步证实了 p53 在顺铂肾毒性过程中诱导 miR-34a 的作用。功能上,用特异性反义寡核苷酸拮抗 miR-34a 会增加顺铂处理过程中的细胞死亡。总的来说,这些结果表明,miR-34a 是通过顺铂肾毒性过程中的 p53 诱导的,并且可能在细胞存活方面发挥细胞保护作用。